Cargando…
Pharmacological Inhibition of STAT3 by Stattic Ameliorates Clinical Symptoms and Reduces Autoinflammation in Myeloid, Lymphoid, and Neuronal Tissue Compartments in Relapsing–Remitting Model of Experimental Autoimmune Encephalomyelitis in SJL/J Mice
Multiple sclerosis (MS) is an immune-mediated inflammatory disease that leads to demyelination and neuronal loss in the central nervous system. Immune cells of lymphoid and myeloid origin play a significant role in the initiation and amplification of neuronal inflammation in MS. STAT3 signaling play...
Autores principales: | Alhazzani, Khalid, Ahmad, Sheikh F., Al-Harbi, Naif O., Attia, Sabry M., Bakheet, Saleh A., Sarawi, Wedad, Alqarni, Saleh A., Algahtani, Mohammad, Nadeem, Ahmed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8308768/ https://www.ncbi.nlm.nih.gov/pubmed/34206429 http://dx.doi.org/10.3390/pharmaceutics13070925 |
Ejemplares similares
-
Auranofin Modulates Thioredoxin Reductase/Nrf2 Signaling in Peripheral Immune Cells and the CNS in a Mouse Model of Relapsing–Remitting EAE
por: Al-Kharashi, Layla A., et al.
Publicado: (2023) -
Cathepsin-B inhibitor CA-074 attenuates retinopathy and optic neuritis in experimental autoimmune encephalomyelitis induced in SJL/J mice
por: Rashid Khan, Mohammad, et al.
Publicado: (2023) -
Disequilibrium in the Thioredoxin Reductase-1/Thioredoxin-1 Redox Couple Is Associated with Increased T-Cell Apoptosis in Children with Autism
por: Alshehri, Samiyah, et al.
Publicado: (2023) -
DAPTA, a C-C Chemokine Receptor 5 (CCR5), Leads to the Downregulation of Notch/NF-κB Signaling and Proinflammatory Mediators in CD40(+) Cells in Experimental Autoimmune Encephalomyelitis Model in SJL/J Mice
por: Alghibiwi, Hanan, et al.
Publicado: (2023) -
Inhibition of ITK Signaling Causes Amelioration in Sepsis-Associated Neuroinflammation and Depression-like State in Mice
por: Algahtani, Mohammad M., et al.
Publicado: (2023)